Product Information
PRAZOSIN 2 MG CAPSULE is a generic product labeled by Biocon Pharma Inc., priced at $0.0863 per EA under NDC 70377006711. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on Oct 21, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377006711
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213406FDA Approved
10/21/2022
TE Code
AB
On Market Since
1/9/2023
Pharmacological Classes
Price Statistics
The NADAC for PRAZOSIN 2 MG CAPSULE has been published 178 times since May 10, 2023, and over the history we have for it it has declined 66.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0863 per EA |
|---|---|
| All-time high | $0.2550 (May 10, 2023) |
| All-time low | $0.0823 (Jun 17, 2026) |
| 52-week high | $0.0928 |
| 52-week low | $0.0823 |
| Median price | $0.0994 |
| Average price | $0.1245 |
| Largest weekly change | -31.4% (Apr 17, 2024) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Prazosin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prazosin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAZOSIN 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PRAZOSIN 2 MG CAPSULE, manufactured by Biocon Pharma Inc., is $0.0863 per EA (NDC 70377006711), effective Sep 30, 2026.
How has the price of PRAZOSIN 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PRAZOSIN 2 MG CAPSULE has declined 66.1%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for PRAZOSIN 2 MG CAPSULE?
Since May 10, 2023, the NADAC for PRAZOSIN 2 MG CAPSULE has ranged from a low of $0.0823 (Jun 17, 2026) to a high of $0.2550 (May 10, 2023), with a median of $0.0994 per EA.
Are there cheaper alternatives to PRAZOSIN 2 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of PRAZOSIN 2 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PRAZOSIN 2 MG CAPSULE?
PRAZOSIN 2 MG CAPSULE (NDC 70377006711) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.